Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2004;110:e39
doi: 10.1161/01.CIR.0000139386.21421.a2
This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mascitelli, L.
Right arrow Articles by Pezzetta, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mascitelli, L.
Right arrow Articles by Pezzetta, F.
Related Collections
Right arrow Risk Factors

(Circulation. 2004;110:e39.)
© 2004 American Heart Association, Inc.


Correspondence

Cardiovascular Protections in Severely Impaired Hemostasis

Luca Mascitelli, MD

Cardiology Service, Casa di Cura "Città di Udine", Udine, Italy

Francesca Pezzetta, MD

Cardiology Service, Ospedale di Tolmezzo, Tolmezzo, Italy

To the Editor:

There is mounting evidence that severely impaired hemostasis is associated with a decreased risk of ischemic cardiovascular disease. In a study with long follow-up, hemophilic patients had an 80% reduction in the risk of fatal ischemic heart disease.1 In clinical practice, occurrence of cardiovascular disease is uncommon in patients with type 3 severe von Willebrand disease, a coagulation disorder in which the severity of bleeding may sometimes resemble that in patients with hemophilia.

However, Srámek et al2 reported that patients with type 3 von Willebrand disease were not protected against the development of early atherosclerosis changes as assessed by measuring carotid and femoral intima-media thickness, thus suggesting that von Willebrand factor is not essential for the development of atherosclerosis. Therefore, in impaired hemostasis, other cardiovascular protective mechanisms could be involved.

An epidemiological study3 found that serum ferritin, a good measurement of body iron stores, emerged as one of the strongest risk factors for progression of carotid atherosclerosis. Furthermore, a recent study4 identified an independent relationship between serum ferritin levels and carotid atherosclerosis. Although ferritin levels have not been shown to be associated with carotid intima-media thickness,4,5 body iron stores may promote atherosclerosis at a stage beyond intima-media thickening. Thus, the protection against ischemic cardiovascular disease in individuals with impaired hemostasis might be related to the decrease of stored tissue iron caused by recurrent bleeding.

References

1. Triemstra M, Rosendaal FR, Smit C, et al. Mortality in patients with hemophilia: changes in a Dutch population from 1986 to 1992 and 1973 to 1986. Ann Intern Med. 1995; 123: 823–827.[Abstract/Free Full Text]

2. Srámek A, Bucciarelli P, Federici AB, et al. Patients with 3 severe von Willebrand disease are not protected against atherosclerosis: results from a multicenter study in 47 patients. Circulation. 2004; 109: 740–744.[Abstract/Free Full Text]

3. Kiechl S, Willeit J, Egger G, et al. Body iron stores and the risk of carotid atherosclerosis: prospective results from the Bruneck study. Circulation. 1997; 96: 3300–3307.[Abstract/Free Full Text]

4. Wolff B, Völzke H, Lüdemann J, et al. Association between high serum ferritin levels and carotid atherosclerosis in the Study of Health In Pomerania (SHIP). Stroke. 2004; 35: 453–457.[Abstract/Free Full Text]

5. Moore M, Folsom AR, Barnes RW, et al. No association between serum ferritin and asymptomatic carotid atherosclerosis. The Atherosclerosis Risk in Communities (ARIC) Study. Am J Epidemiol. 1995; 141: 719–723.[Abstract/Free Full Text]





This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mascitelli, L.
Right arrow Articles by Pezzetta, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mascitelli, L.
Right arrow Articles by Pezzetta, F.
Related Collections
Right arrow Risk Factors